{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T22:47:07Z","timestamp":1794955627870,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070831"],"award-info":[{"award-number":["82070831"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871163"],"award-info":[{"award-number":["31871163"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471000"],"award-info":[{"award-number":["81471000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dalian Leading Talent Project"},{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2020-MS-247"],"award-info":[{"award-number":["2020-MS-247"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"publisher","award":["2021YFA0805100"],"award-info":[{"award-number":["2021YFA0805100"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nonalcoholic fatty liver disease (NAFLD) is closely associated with insulin resistance (IR) and type 2 diabetes mellitus (T2DM), which are all complex metabolic disorders. Selenoprotein S (SelS) is an endoplasmic reticulum (ER) resident selenoprotein involved in regulating ER stress and has been found to participate in the occurrence and development of IR and T2DM. However, the potential role and mechanism of SelS in NAFLD remains unclear. Here, we analyzed SelS expression in the liver of high-fat diet (HFD)-fed mice and obese T2DM model (\n                    <jats:italic>db\/db<\/jats:italic>\n                    ) mice and generated hepatocyte-specific SelS knockout (\n                    <jats:italic>SelS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>H-KO<\/jats:italic>\n                    <\/jats:sup>\n                    ) mice using the Cre-loxP system. We showed that hepatic SelS expression levels were significantly downregulated in HFD-fed mice and\n                    <jats:italic>db\/db<\/jats:italic>\n                    mice. Hepatic SelS deficiency markedly increased ER stress markers in the liver and caused hepatic steatosis via increased fatty acid uptake and reduced fatty acid oxidation. Impaired insulin signaling was detected in the liver of\n                    <jats:italic>SelS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>H-KO<\/jats:italic>\n                    <\/jats:sup>\n                    mice with decreased phosphorylation levels of insulin receptor substrate 1 (IRS1) and protein kinase B (PKB\/Akt), which ultimately led to disturbed glucose homeostasis. Meanwhile, our results showed hepatic protein kinase C\u025b (PKC\u025b) activation participated in the negative regulation of insulin signaling in\n                    <jats:italic>SelS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>H-KO<\/jats:italic>\n                    <\/jats:sup>\n                    mice. Moreover, the inhibitory effect of SelS on hepatic steatosis and IR was confirmed by SelS overexpression in primary hepatocytes in vitro. Thus, we conclude that hepatic SelS plays a key role in regulating hepatic lipid accumulation and insulin action, suggesting that SelS may be a potential intervention target for the prevention and treatment of NAFLD and T2DM.\n                  <\/jats:p>","DOI":"10.1038\/s41419-022-04716-w","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T15:02:48Z","timestamp":1648479768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4119-2585","authenticated-orcid":false,"given":"Lu","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyuan","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2694-1971","authenticated-orcid":false,"given":"Yingjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-6969","authenticated-orcid":false,"given":"Jianling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"4716_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"4716_CR2","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75:3313\u20133327.","journal-title":"Cell Mol Life Sci."},{"key":"4716_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/hep.26672","volume":"59","author":"AL Birkenfeld","year":"2014","unstructured":"Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology. 2014;59:713\u2013723.","journal-title":"Hepatology"},{"key":"4716_CR4","doi-asserted-by":"publisher","first-page":"18273","DOI":"10.1073\/pnas.0608537103","volume":"103","author":"KF Petersen","year":"2006","unstructured":"Petersen KF, Dufour S, Feng J, Befroy D, Dziura J, Dalla Man C, et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci USA. 2006;103:18273\u201318277.","journal-title":"Proc Natl Acad Sci USA."},{"key":"4716_CR5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","volume":"54","author":"KF Petersen","year":"2005","unstructured":"Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54:603\u2013608.","journal-title":"Diabetes"},{"key":"4716_CR6","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98:2133\u20132223.","journal-title":"Physiol Rev."},{"key":"4716_CR7","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.2337\/diabetes.51.6.1859","volume":"51","author":"K Walder","year":"2002","unstructured":"Walder K, Kantham L, McMillan JS, Trevaskis J, Kerr L, De Silva A, et al. Tanis: a link between type 2 diabetes and inflammation? Diabetes. 2002;51:1859\u20131866.","journal-title":"Diabetes"},{"key":"4716_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.metabol.2010.05.011","volume":"60","author":"M Olsson","year":"2011","unstructured":"Olsson M, Olsson B, Jacobson P, Thelle DS, Bjorkegren J, Walley A, et al. Expression of the selenoprotein S (SELS) gene in subcutaneous adipose tissue and SELS genotype are associated with metabolic risk factors. Metabolism. 2011;60:114\u2013120.","journal-title":"Metabolism"},{"key":"4716_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/00029330-200807010-00003","volume":"121","author":"JL Du","year":"2008","unstructured":"Du JL, Sun CK, Lu B, Men LL, Yao JJ, An LJ, et al. Association of SelS mRNA expression in omental adipose tissue with Homa-IR and serum amyloid A in patients with type 2 diabetes mellitus. Chin Med J. 2008;121:1165\u20131168.","journal-title":"Chin Med J."},{"key":"4716_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0014-5793(04)00296-0","volume":"563","author":"Y Gao","year":"2004","unstructured":"Gao Y, Feng HC, Walder K, Bolton K, Sunderland T, Bishara N, et al. Regulation of the selenoprotein SelS by glucose deprivation and endoplasmic reticulum stress\u2014SelS is a novel glucose-regulated protein. FEBS Lett. 2004;563:185\u2013190.","journal-title":"FEBS Lett"},{"key":"4716_CR11","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1530\/JOE-19-0292","volume":"244","author":"L Men","year":"2020","unstructured":"Men L, Yao J, Yu S, Li Y, Cui S, Jin S, et al. Selenoprotein S regulates adipogenesis through IRE1alpha-XBP1 pathway. J Endocrinol. 2020;244:431\u2013443.","journal-title":"J Endocrinol"},{"key":"4716_CR12","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1016\/j.bbrc.2018.08.057","volume":"503","author":"L Men","year":"2018","unstructured":"Men L, Yu S, Yao J, Li Y, Ren D, Du J. Selenoprotein S protects against adipocyte death through mediation of the IRE1alpha-sXBP1 pathway. Biochem Biophys Res Commun. 2018;503:2866\u20132871.","journal-title":"Biochem Biophys Res Commun."},{"key":"4716_CR13","doi-asserted-by":"publisher","first-page":"929","DOI":"10.2337\/diabetes.52.4.929","volume":"52","author":"Y Gao","year":"2003","unstructured":"Gao Y, Walder K, Sunderland T, Kantham L, Feng HC, Quick M, et al. Elevation in tanis expression alters glucose metabolism and insulin sensitivity in H4IIE cells. Diabetes. 2003;52:929\u2013934.","journal-title":"Diabetes"},{"key":"4716_CR14","doi-asserted-by":"publisher","first-page":"110963","DOI":"10.1016\/j.exger.2020.110963","volume":"137","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Yu S, Yu H, Yao J, Men L, Li Y, et al. Selenoprotein S attenuates endothelial dysfunction in a diabetic vascular chip. Exp Gerontol. 2020;137:110963.","journal-title":"Exp Gerontol."},{"key":"4716_CR15","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.2337\/diabetes.53.6.1424","volume":"53","author":"HKR Karlsson","year":"2004","unstructured":"Karlsson HKR, Tsuchida H, Lake S, Koistinen HA, Krook A. Relationship between serum amyloid A level and Tanis\/SelS mRNA expression in skeletal muscle and adipose tissue from healthy and type 2 diabetic subjects. Diabetes. 2004;53:1424\u20131428.","journal-title":"Diabetes"},{"key":"4716_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.imlet.2020.03.003","volume":"222","author":"Z Chen","year":"2020","unstructured":"Chen Z, Liu Y, Yang L, Liu P, Zhang Y, Wang X. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. Immunol Lett. 2020;222:40\u201348.","journal-title":"Immunol Lett."},{"key":"4716_CR17","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jhep.2018.06.008","volume":"69","author":"C Lebeaupin","year":"2018","unstructured":"Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69:927\u2013947.","journal-title":"J Hepatol"},{"key":"4716_CR18","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1126\/science.1158042","volume":"320","author":"AH Lee","year":"2008","unstructured":"Lee AH, Scapa EF, Cohen DE, Glimcher LH. Regulation of hepatic lipogenesis by the transcription factor XBP1. Science. 2008;320:1492\u20131496.","journal-title":"Science"},{"key":"4716_CR19","doi-asserted-by":"publisher","first-page":"25350","DOI":"10.1074\/jbc.M113.470526","volume":"288","author":"GZ Xiao","year":"2013","unstructured":"Xiao GZ, Zhang T, Yu SB, Lee SJ, Calabuig-Navarro V, Yamauchi J, et al. ATF4 Protein Deficiency Protects against High Fructose-induced Hypertriglyceridemia in Mice. J Biol Chem. 2013;288:25350\u201325361.","journal-title":"J Biol Chem"},{"key":"4716_CR20","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/JLB.3MA1119-173R","volume":"107","author":"J Wu","year":"2020","unstructured":"Wu J, Wu D, Zhang L, Lin C, Liao J, Xie R, et al. NK cells induce hepatic ER stress to promote insulin resistance in obesity through osteopontin production. J Leukoc Biol. 2020;107:589\u2013596.","journal-title":"J Leukoc Biol"},{"key":"4716_CR21","doi-asserted-by":"publisher","first-page":"29941","DOI":"10.1074\/jbc.M115.680215","volume":"290","author":"JH Lee","year":"2015","unstructured":"Lee JH, Park KJ, Jang JK, Jeon YH, Ko KY, Kwon JH, et al. Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation. J Biol Chem. 2015;290:29941\u201329952.","journal-title":"J Biol Chem."},{"key":"4716_CR22","doi-asserted-by":"publisher","first-page":"13758","DOI":"10.1074\/jbc.M113.534529","volume":"289","author":"JH Lee","year":"2014","unstructured":"Lee JH, Kwon JH, Jeon YH, Ko KY, Lee S-R, Kim IY. Pro(178) and Pro(183) of selenoprotein S are essential residues for interaction with p97(VCP) during endoplasmic reticulum-associated degradation. J Biol Chem. 2014;289:13758\u201313768.","journal-title":"J Biol Chem."},{"key":"4716_CR23","doi-asserted-by":"publisher","first-page":"14132","DOI":"10.1073\/pnas.0505006102","volume":"102","author":"YH Ye","year":"2005","unstructured":"Ye YH, Shibata Y, Kikkert M, van Voorden S, Wiertz E, Rapoport TA. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc Natl Acad Sci USA. 2005;102:14132\u201314138.","journal-title":"Proc Natl Acad Sci USA."},{"key":"4716_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.bbagen.2010.01.005","volume":"1800","author":"S Du","year":"2010","unstructured":"Du S, Liu H, Huang K. Influence of SelS gene silence on beta-mercaptoethanol-mediated endoplasmic reticulum stress and cell apoptosis in HepG2 cells. Biochim Biophys Acta. 2010;1800:511\u2013517.","journal-title":"Biochim Biophys Acta"},{"key":"4716_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12031-008-9069-3","volume":"35","author":"N Fradejas","year":"2008","unstructured":"Fradejas N, Pastor MD, Mora-Lee S, Tranque P, Calvo S. SEPS1 gene is activated during astrocyte ischemia and shows prominent antiapoptotic effects. J Mol Neurosci. 2008;35:259\u2013265.","journal-title":"J Mol Neurosci."},{"key":"4716_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbrc.2006.12.183","volume":"354","author":"KH Kim","year":"2007","unstructured":"Kim KH, Gao Y, Walder K, Collier GR, Skelton J, Kissebah AH. SEPS1 protects RAW264.7 cells from pharmacological ER stress agent-induced apoptosis. Biochem Biophys Res Commun. 2007;354:127\u2013132.","journal-title":"Biochem Biophys Res Commun."},{"key":"4716_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/jcb.25254","volume":"117","author":"Y Ye","year":"2016","unstructured":"Ye Y, Fu F, Li X, Yang J, Liu H. Selenoprotein S is highly expressed in the blood vessels and prevents vascular smooth muscle cells from apoptosis. J Cell Biochem. 2016;117:106\u2013117.","journal-title":"J Cell Biochem."},{"key":"4716_CR28","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/glia.21168","volume":"59","author":"N Fradejas","year":"2011","unstructured":"Fradejas N, Serrano-Perez MD, Tranque P, Calvo S. Selenoprotein S expression in reactive astrocytes following brain injury. Glia. 2011;59:959\u2013972.","journal-title":"Glia"},{"key":"4716_CR29","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226:497\u2013509.","journal-title":"J Biol Chem"},{"key":"4716_CR30","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1002\/hep.26170","volume":"57","author":"N Kumashiro","year":"2013","unstructured":"Kumashiro N, Yoshimura T, Cantley JL, Majumdar SK, Guebre-Egziabher F, Kursawe R, et al. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. Hepatology. 2013;57:1763\u20131772.","journal-title":"Hepatology"},{"key":"4716_CR31","doi-asserted-by":"publisher","first-page":"8166","DOI":"10.1073\/pnas.1921694117","volume":"117","author":"Y Nozaki","year":"2020","unstructured":"Nozaki Y, Petersen MC, Zhang D, Vatner DF, Perry RJ, Abulizi A, et al. Metabolic control analysis of hepatic glycogen synthesis in vivo. Proc Natl Acad Sci USA. 2020;117:8166\u20138176.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4716_CR32","doi-asserted-by":"crossref","unstructured":"Cohen M, Kitsberg D, Tsytkin S, Shulman M, Aroeti B, Nahmias, Y. Live imaging of GLUT2 glucose-dependent trafficking and its inhibition in polarized epithelial cysts. Open Biol. 2014;4:140091.","DOI":"10.1098\/rsob.140091"},{"key":"4716_CR33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmet.2009.10.007","volume":"10","author":"DM Erion","year":"2009","unstructured":"Erion DM, Ignatova ID, Yonemitsu S, Nagai Y, Chatterjee P, Weismann D, et al. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metab. 2009;10:499\u2013506.","journal-title":"Cell Metab"},{"key":"4716_CR34","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11684-019-0711-y","volume":"13","author":"X Li","year":"2019","unstructured":"Li X. The FGF metabolic axis. Front Med. 2019;13:511\u2013530.","journal-title":"Front Med"},{"key":"4716_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"OM Kuro","year":"2019","unstructured":"Kuro OM. The Klotho proteins in health and disease. Nat Rev Nephrol. 2019;15:27\u201344.","journal-title":"Nat Rev Nephrol"},{"key":"4716_CR36","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005;115:1343\u20131351.","journal-title":"J Clin Invest"},{"key":"4716_CR37","doi-asserted-by":"publisher","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"JK Reddy","year":"2006","unstructured":"Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006;290:G852\u2013858.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4716_CR38","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdiacomp.2016.09.001","volume":"31","author":"JS Moon","year":"2017","unstructured":"Moon JS, Karunakaran U, Elumalai S, Lee IK, Lee HW, Kim YW, et al. Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells. J Diabetes Complications. 2017;31:21\u201330.","journal-title":"J Diabetes Complications"},{"key":"4716_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.14218\/JCTH.2019.00028","volume":"7","author":"DH Akhtar","year":"2019","unstructured":"Akhtar DH, Iqbal U, Vazquez-Montesino LM, Dennis BB, Ahmed A. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2019;7:362\u2013370.","journal-title":"J Clin Transl Hepatol"},{"key":"4716_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.biopha.2018.05.098","volume":"105","author":"MA Dallak","year":"2018","unstructured":"Dallak MA. Acylated ghrelin induces but deacylated ghrelin prevents hepatic steatosis and insulin resistance in lean rats: Effects on DAG\/ PKC\/JNK pathway. Biomed Pharmacother 2018;105:299\u2013311.","journal-title":"Biomed Pharmacother"},{"key":"4716_CR41","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nature13478","volume":"510","author":"RJ Perry","year":"2014","unstructured":"Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510:84\u201391.","journal-title":"Nature"},{"key":"4716_CR42","doi-asserted-by":"publisher","first-page":"32345","DOI":"10.1074\/jbc.M313478200","volume":"279","author":"VT Samuel","year":"2004","unstructured":"Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J Biol Chem 2004;279:32345\u201332353.","journal-title":"J Biol Chem"},{"key":"4716_CR43","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1172\/JCI86013","volume":"126","author":"MC Petersen","year":"2016","unstructured":"Petersen MC, Madiraju AK, Gassaway BM, Marcel M, Nasiri AR, Butrico G, et al. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest. 2016;126:4361\u20134371.","journal-title":"J Clin Invest"},{"key":"4716_CR44","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1006\/abbi.1997.0334","volume":"348","author":"R Gopalakrishna","year":"1997","unstructured":"Gopalakrishna R, Gundimeda U, Chen ZH. Cancer-preventive selenocompounds induce a specific redox modification of cysteine-rich regions in Ca(2+)-dependent isoenzymes of protein kinase C. Arch Biochem Biophys 1997;348:25\u201336.","journal-title":"Arch Biochem Biophys"},{"key":"4716_CR45","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1074\/jbc.R800045200","volume":"284","author":"J Lu","year":"2009","unstructured":"Lu J, Holmgren A. Selenoproteins. J Biol Chem 2009;284:723\u2013727.","journal-title":"J Biol Chem"},{"key":"4716_CR46","doi-asserted-by":"publisher","first-page":"16381","DOI":"10.1073\/pnas.1113359108","volume":"108","author":"N Kumashiro","year":"2011","unstructured":"Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, et al. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci U S A 2011;108:16381\u201316385.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4716_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","volume":"5","author":"T Inagaki","year":"2007","unstructured":"Inagaki T, Dutchak P, Zhao G, Ding X, Gautron L, Parameswara V, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5:415\u2013425.","journal-title":"Cell Metab"},{"key":"4716_CR48","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","volume":"139","author":"J Dushay","year":"2010","unstructured":"Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, et al. Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease. Gastroenterology. 2010;139:456\u2013463.","journal-title":"Gastroenterology"},{"key":"4716_CR49","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jhep.2010.05.018","volume":"53","author":"HT Li","year":"2010","unstructured":"Li HT, Fang QC, Gao F, Fan J, Zhou JA, Wang XY, et al. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. J Hepatol 2010;53:934\u2013940.","journal-title":"J Hepatol"},{"key":"4716_CR50","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1530\/EC-20-0152","volume":"9","author":"H Keinicke","year":"2020","unstructured":"Keinicke H, Sun G, Mentzel CMJ, Fredholm M, John LM, Andersen B, et al. FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation. Endocr Connect. 2020;9:755\u2013768.","journal-title":"Endocr Connect"},{"key":"4716_CR51","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1172\/JCI23606","volume":"115","author":"A Kharitonenkov","year":"2005","unstructured":"Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005;115:1627\u20131635.","journal-title":"J Clin Invest"},{"key":"4716_CR52","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3389\/fendo.2015.00147","volume":"6","author":"T Inagaki","year":"2015","unstructured":"Inagaki T. Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD. Front Endocrinol (Lausanne). 2015;6:147.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"4716_CR53","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.cmet.2013.04.005","volume":"17","author":"Z Lin","year":"2013","unstructured":"Lin Z, Tian H, Lam KS, Lin S, Hoo RC, Konishi M, et al. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab. 2013;17:779\u2013789.","journal-title":"Cell Metab"},{"key":"4716_CR54","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s11655-017-2810-4","volume":"23","author":"DW Ye","year":"2017","unstructured":"Ye DW, Rong XL, Xu AM, Guo J. Liver-adipose tissue crosstalk: A key player in the pathogenesis of glucolipid metabolic disease. Chin J Integr Med 2017;23:410\u2013414.","journal-title":"Chin J Integr Med"},{"key":"4716_CR55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.molmet.2019.08.020","volume":"29","author":"C Zhao","year":"2019","unstructured":"Zhao C, Liu L, Liu Q, Li F, Zhang L, Zhu F, et al. Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice. Mol Metab. 2019;29:145\u2013157.","journal-title":"Mol Metab"},{"key":"4716_CR56","doi-asserted-by":"publisher","first-page":"108256","DOI":"10.1016\/j.jnutbio.2019.108256","volume":"75","author":"Q Liu","year":"2020","unstructured":"Liu Q, Liu Y, Li F, Gu Z, Liu M, Shao T, et al. Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. J Nutr Biochem 2020;75:108256.","journal-title":"J Nutr Biochem"},{"key":"4716_CR57","doi-asserted-by":"publisher","first-page":"R380","DOI":"10.1152\/ajpregu.00244.2017","volume":"315","author":"AB Addinsall","year":"2018","unstructured":"Addinsall AB, Wright CR, Shaw CS, McRae NL, Forgan LG, Weng CH, et al. Deficiency of selenoprotein S, an endoplasmic reticulum resident oxidoreductase, impairs the contractile function of fast-twitch hindlimb muscles. Am J Physiol Regul Integr Comp Physiol. 2018;315:R380\u2013R396.","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"4716_CR58","doi-asserted-by":"publisher","first-page":"7415","DOI":"10.1039\/D1FO01241J","volume":"12","author":"X Zou","year":"2021","unstructured":"Zou X, Ahmad MI, Zhao D, Zhang M, Li C. Glutaredoxin1 knockout promotes high-fat diet-induced obesity in male mice but not in female ones. Food Funct. 2021;12:7415\u20137427.","journal-title":"Food Funct"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04716-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:55:36Z","timestamp":1669283736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04716-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["4716"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04716-w","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"21 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal study was reviewed and approved by the Animal Experimental Ethics Committee of Dalian Medical University, Dalian, China (NO. AEE18084).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"275"}}